Type II hyperprolinemia:: a case report

被引:0
|
作者
Önenli-Mungan, N
Yüksel, B
Elkay, M
Topaloglu, AK
Baykal, T
Özer, G
机构
[1] Cukurova Univ, Fac Med, Dept Pediat Endocrinol & Metab, Adana, Turkey
[2] Cukurova Univ, Fac Med, Dept Pediat Neurol, Adana, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Dept Pediat Metab & Nutr, Istanbul, Turkey
关键词
hyperprolinemia;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hyperprolinemia type II (HP II) is a rare inherited metabolic disease due to the deficiency of pyroline-5-carboxylate dehydrogenase. It is generally believed to be a benign condition although some patients have neurological problems such as refractory convulsions. Here we report a six-year-old girl with HP II who admitted to our hospital with recurrent seizure refractory to multiple antiepileptic drugs. She was the third child of healthy, consanguineous parents. The family history was negative for neurological and renal disorders. On physical examination, she had no facial dysmorphy; the anthropometric measurements, and systemic and neurological examinations were normal. Mental and motor development was appropriate for her age. Laboratory findings revealed elevated levels of proline, glycine, and ornithine in serum and pyrroline-5-carboxylate and hydroxproline in urine. Cerebral computerized tomography and magnetic resonance imaging were both normal. Electroencephalogram showed a very active epileptic abnormality; partial control of seizures was achieved by two antiepileptics. Increased plasma glycine and ornithine levels are the unique features of our case when compared to the other HP II cases reported in the literature.
引用
收藏
页码:167 / 169
页数:3
相关论文
共 50 条
  • [31] Identification of Δ-1-pyrroline-5-carboxylate derived biomarkers for hyperprolinemia type II
    Merx, Jona
    van Outersterp, Rianne E.
    Engelke, Udo F. H.
    Hendriks, Veronique
    Wevers, Ron A.
    Huigen, Marleen C. D. G.
    Waterval, Huub W. A. H.
    Korver-Keularts, Irene M. L. W.
    Mecinovie, Jasmin
    Rutjes, Floris P. J. T.
    Oomens, Jos
    Coene, Karlien L. M.
    Martens, Jonathan
    Boltje, Thomas J.
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [32] Type II hyperprolinemia: Cloning and expression in yeast of cDNAs encoding human delta(1)-pyrroline-5-carboxylate (P5C) dehydrogenase and delineation of mutations responsible for type II hyperprolinemia (HP II).
    Hu, CA
    Geraghty, M
    Lin, WW
    Valle, D
    PEDIATRIC RESEARCH, 1996, 39 (04) : 860 - 860
  • [33] Identification of Δ-1-pyrroline-5-carboxylate derived biomarkers for hyperprolinemia type II
    Jona Merx
    Rianne E. van Outersterp
    Udo F. H. Engelke
    Veronique Hendriks
    Ron A. Wevers
    Marleen C. D. G. Huigen
    Huub W. A. H. Waterval
    Irene M. L. W. Körver-Keularts
    Jasmin Mecinović
    Floris P. J. T. Rutjes
    Jos Oomens
    Karlien L. M. Coene
    Jonathan Martens
    Thomas J. Boltje
    Communications Biology, 5
  • [34] DENTINOGENESIS IMPERFECTA TYPE II. CASE REPORT
    Omana, Carlos
    Jerez, Elsy
    Guevara, Carlos
    Alvarez, Giancarlos
    ACTA BIOCLINICA, 2014, 4 (07): : 132 - +
  • [36] Congenital Dyserythropoietic Anemia Type II: A Case Report
    Hassan, Muhammad Mujeeb
    Mirza, Azka A.
    Zaidi, Rafay
    Malik, Moeena
    Javaid, Maham
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [38] Tuina for type II diabetes mellitus: A case report
    Pan Yun-hua
    Geng Tao
    Journal of Acupuncture and Tuina Science, 2004, 2 (3) : 61 - 62
  • [40] Severe hydrocephalus in mucolipidosis type II: A case report
    Clark, Heather
    Laney, Dawn
    Fernhoff, Paul
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (02) : S18 - S18